Table 2.
Known miRNAs present in hypoxia treated and control roots
miRNA family | miRNA | Sequence | Untreated reads | Hypoxia reads | Relative changea |
156 | 156a,b,c,d,e,f | UGACAGAAGAGAGUGAGCAC | 4 382 | 6 958 | 1.35* |
156g | CGACAGAAGAGAGUGAGCAC | 17 | 55 | 2.75* | |
156h | UGACAGAAGAAAGAGAGCAC | 2 | 5 | 2.13 | |
157 | 157a,b,c | UUGACAGAAGAUAGAGAGCAC | 4 119 | 8 409 | 1.74* |
157d | UGACAGAAGAUAGAGAGCAC | 58 | 282 | 4.14* | |
158 | 158a | UCCCAAAUGUAGACAAAGCA | 2 427 | 7 981 | 2.80* |
158b | CCCCAAAUGUAGACAAAGCA | 34 | 69 | 1.73* | |
159 | 159a | UUUGGAUUGAAGGGAGCUCUA | 73 | 162 | 1.89* |
159b | UUUGGAUUGAAGGGAGCUCUU | 11 | 14 | 1.08 | |
160 | 160a,b,c | UGCCUGGCUCCCUGUAUGCCA | 1 | 2 | 1.70 |
161 | 161.1 | UGAAAGUGACUACAUCGGGGU | 39 | 65 | 1.42* |
161.2 | UCAAUGCAUUGAAAGUGACUA | 20 | 119 | 5.06* | |
163 | 163 | UUGAAGAGGACUUGGAACUUCGAU | 2 | 4 | 1.70 |
164 | 164a,b | UGGAGAAGCAGGGCACGUGCA | 2 362 | 3 151 | 1.13* |
164c | UGGAGAAGCAGGGCACGUGCG | 452 | 550 | 1.04 | |
165 | 165a,b | UCGGACCAGGCUUCAUCCCCC | 14 977 | 15 750 | 0.89* |
166 | 166a,b,c,d,e,f,g | UCGGACCAGGCUUCAUUCCCC | 79 589 | 84 844 | 0.91* |
167 | 167a,b | UGAAGCUGCCAGCAUGAUCUA | 1 429 | 1 709 | 1.02 |
167d | UGAAGCUGCCAGCAUGAUCUGG | 1 | 4 | 3.40* | |
168 | 168a,b | UCGCUUGGUGCAGGUCGGGAA | 7 584 | 9 932 | 1.11* |
169 | 169a | CAGCCAAGGAUGACUUGCCGA | 10 | 3 | 0.26* |
169b,c | CAGCCAAGGAUGACUUGCCGG | 1 | 8 | 6.80* | |
169d,e,f,g | UGAGCCAAGGAUGACUUGCCG | 92 | 61 | 0.56* | |
169h,i,j,k,l,m,n | UAGCCAAGGAUGACUUGCCUG | 3 | 6 | 1.70 | |
171 | 171a | UGAUUGAGCCGCGCCAAUAUC | 0 | 2 | NA** |
172 | 172a, b | AGAAUCUUGAUGAUGCUGCAU | 15 | 93 | 5.27* |
172c,d | AGAAUCUUGAUGAUGCUGCAG | 2 | 2 | 0.85 | |
172e | GGAAUCUUGAUGAUGCUGCAU | 4 | 2 | 0.43 | |
173 | 173 | UUCGCUUGCAGAGAGAAAUCAC | 213 | 375 | 1.50* |
319 | 319a,b | UUGGACUGAAGGGAGCUCCCU | 1 | 0 | NA |
390 | 390a,b | AAGCUCAGGAGGGAUAGCGCC | 1 652 | 3 124 | 1.61* |
391 | 391 | UUCGCAGGAGAGAUAGCGCCA | 25 | 77 | 2.62* |
395 | 395a,d,e | CUGAAGUGUUUGGGGGAACUC | 1 | 2 | 1.70 |
395b,c,f | CUGAAGUGUUUGGGGGGACUC | 2 | 5 | 2.13 | |
399 | 399a | UGCCAAAGGAGAUUUGCCCUG | 1 | 1 | 0.85 |
399b,c | UGCCAAAGGAGAGUUGCCCUG | 4 | 3 | 0.64 | |
399d | UGCCAAAGGAGAUUUGCCCCG | 5 | 1 | 0.17 | |
399f | UGCCAAAGGAGAUUUGCCCGG | 11 | 12 | 0.93 | |
400 | 400 | UAUGAGAGUAUUAUAAGUCAC | 2 | 1 | 0.43 |
403 | 403 | UUAGAUUCACGCACAAACUCG | 2 | 4 | 1.70 |
408 | 408 | AUGCACUGCCUCUUCCCUGGC | 125 | 138 | 0.94 |
447 | 447a,b | UUGGGGACGAGAUGUUUUGUUG | 5 | 3 | 0.51 |
775 | 775 | UUCGAUGUCUAGCAGUGCCA | 9 | 27 | 2.55* |
780 | 780.1 | UCUAGCAGCUGUUGAGCAGGU | 0 | 1 | NA |
822 | 822 | UGCGGGAAGCAUUUGCACAUG | 115 | 121 | 0.89 |
823 | 823 | UGGGUGGUGAUCAUAUAAGAU | 6 | 10 | 1.42 |
824 | 824 | UAGACCAUUUGUGAGAAGGGA | 20 | 39 | 1.66* |
827 | 827 | UUAGAUGACCAUCAACAAACU | 10 | 20 | 1.70 |
829 | 829.1 | AGCUCUGAUACCAAAUGAUGGAAU | 1 564 | 1 228 | 0.67* |
829.2 | CAAAUUAAAGCUUCAAGGUAG | 1 | 0 | NA | |
830 | 830 | UAACUAUUUUGAGAAGAAGUG | 1 | 0 | NA |
837 | 837-3p | AAACGAACAAAAAACUGAUGG | 14 | 27 | 1.64* |
837-5p | AUCAGUUUCUUGUUCGUUUCA | 1 | 1 | 0.85 | |
838 | 838 | UUUUCUUCUACUUCUUGCACA | 0 | 1 | NA |
841 | 841 | UACGAGCCACUUGAAACUGAA | 1 | 0 | NA |
842 | 842 | UCAUGGUCAGAUCCGUCAUCC | 23 | 24 | 0.89 |
843 | 843 | UUUAGGUCGAGCUUCAUUGGA | 0 | 2 | NA |
846 | 846 | UUGAAUUGAAGUGCUUGAAUU | 3 | 3 | 0.85 |
848 | 848 | UGACAUGGGACUGCCUAAGCUA | 10 | 14 | 1.19 |
852 | 852 | AAGAUAAGCGCCUUAGUUCUG | 1 | 2 | 1.70 |
860 | 860 | UCAAUAGAUUGGACUAUGUAU | 0 | 2 | NA |
861 | 861-5p | CCUUGGAGAAAUAUGCGUCAA | 1 | 0 | NA |
862 | 862-5p | UCCAAUAGGUCGAGCAUGUGC | 0 | 3 | NA |
869 | 869.2 | UCUGGUGUUGAGAUAGUUGAC | 50 | 57 | 0.97 |
1888 | 1888 | UAAGUUAAGAUUUGUGAAGAA | 0 | 2 | NA |
Relative change is the ratio of hypoxia-treated sample to the control and takes into account the differences in total read between samples. *P value ≤0.01. **Relative change was not calculated as they contained 0 reads in one sample.